Bookedited by Robin Ganellin, Stanley Roberts, Roy Jefferis.
Contents:
Chapter 1. Introduction to enzymes, receptors and the action of small molecule drugs
chapter 2. Protein structure and function
chapter 3. The small molecule drug discovery process : from target selection to candidate selection
chapter 4. Protein therapeutics (introduction to biopharmaceuticals)
chapter 5. Similarities and differences in the discovery and use of biopharmaceuticals and small-molecule chemotherapeutics
chapter 6. Therapies for type 2 diabetes : modulating the incretin pathway using small molecule peptidase inhibitors or peptide mimetics
chapter 7. The structure and business of biopharmaceutical companies including the management of risks and resources
chapter 8. Discovery and development of the anticancer agent gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase
chapter 9. Targeting HER2 by monoclonal antibodies for cancer therapy
chapter 10. Recombinant human erythropoietin and its analogues
chapter 11. Lysosomal storage disorders : current treatments and future directions
chapter 12. Hormone replacement therapy
chapter 13. Design of the anti-HIV protease inhibitor darunavir
chapter 14. The case of anti-TNF agents
chapter 15. Discovery of the cholesterol absorption inhibitor, ezetimibe.